CME Group Inc. (NASDAQ:CME) will issue its quarterly earnings data before the market opens on Tuesday, August 1st. Analysts expect the company to announce earnings of $1.21 per share for the quarter.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.02. The firm had revenue of $929 million for the quarter, compared to the consensus estimate of $932.06 million. CME Group had a return on equity of 7.43% and a net margin of 43.62%. The company’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.15 earnings per share. On average, analysts expect CME Group to post $4.85 EPS for the current fiscal year and $5.28 EPS for the next fiscal year.

CME Group Inc. (NASDAQ CME) opened at 120.42 on Tuesday. The stock has a 50 day moving average price of $123.54 and a 200 day moving average price of $120.32. The stock has a market cap of $40.92 billion, a P/E ratio of 26.06 and a beta of 0.74. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96.

The firm also recently declared a quarterly dividend, which was paid on Monday, June 26th. Investors of record on Friday, June 9th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend was Wednesday, June 7th. CME Group’s payout ratio is 57.14%.

COPYRIGHT VIOLATION NOTICE: “CME Group Inc. (CME) to Release Quarterly Earnings on Tuesday” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/07/25/cme-group-inc-cme-to-release-quarterly-earnings-on-tuesday.html.

A number of brokerages have recently commented on CME. UBS AG reaffirmed a “buy” rating and set a $134.00 target price (down from $136.00) on shares of CME Group in a research report on Monday, June 5th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $127.00 price objective on shares of CME Group in a report on Friday, July 14th. Deutsche Bank AG cut their price objective on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th. Finally, BidaskClub raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. CME Group presently has an average rating of “Hold” and a consensus price target of $128.00.

In other news, insider Kathleen M. Cronin sold 8,125 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total value of $1,034,718.75. Following the transaction, the insider now directly owns 38,174 shares in the company, valued at approximately $4,861,458.90. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $124.50, for a total transaction of $311,250.00. Following the completion of the transaction, the chief financial officer now owns 38,495 shares in the company, valued at $4,792,627.50. The disclosure for this sale can be found here. Insiders sold a total of 48,754 shares of company stock worth $5,955,724 over the last quarter. 0.61% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.